Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05906875 · ClinicalTrials.gov registry record · NA
A Novel Balance Program to Improve Balance in People With Parkinson's Disease
A NA study, sponsored by New York Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT05906875: Completed NA study, sponsored by New York Institute of Technology.
NCT05906875 is a NA study that has completed, run by New York Institute of Technology. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05906875, a NA study, has completed, sponsored by New York Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this exploratory single-blinded feasibility study is to explore the effects of a lateral stepping program integrated into an existing community-based group exercise program for people with PD. The researchers hypothesize that participation in a lateral stepping program a minimum of 2 times/week for 8 weeks, in addition to RSB class participation is feasible in middle to late stage PD and will decrease fall risk factors. The researchers also hypothesize that the integration of this program into an existing community-based RSB program will be deemed feasible as shown by the number of sessions attended by each participant.
Primary Outcome
Performance measure, validated in people with PD, aimed to target and identify 6 different balance control systems
Interventions
- OTHER Lateral Stepping Exercise 1
- OTHER Lateral Stepping Exercise 2
- OTHER Lateral Stepping Exercise 3
- OTHER Lateral Stepping Exercise 4
- OTHER Lateral Stepping Exercise 5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2023-09-20 |
| Est. Completion | 2023-12-18 |
| Phase | NA |
What the finished NCT05906875 record still lists
NCT05906875 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 5 interventions - of which Lateral Stepping Exercise 1 is the first listed.
NCT05906875 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05906875 about?
NCT05906875 is a clinical study titled "A Novel Balance Program to Improve Balance in People With Parkinson's Disease". The purpose of this exploratory single-blinded feasibility study is to explore the effects of a lateral stepping program integrated into an existing community-based group exercise program for people with PD. The researchers hypothesize that participation in a lateral stepping program a minimum of 2 ...
What is the current status of trial NCT05906875?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2023-09-20. Estimated completion is 2023-12-18.
What interventions are being tested in trial NCT05906875?
The interventions under investigation include: Lateral Stepping Exercise 1 (OTHER), Lateral Stepping Exercise 2 (OTHER), Lateral Stepping Exercise 3 (OTHER), Lateral Stepping Exercise 4 (OTHER), Lateral Stepping Exercise 5 (OTHER).
Who is sponsoring clinical trial NCT05906875?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05906875's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI